Skip to main content
Method for the in vitro differentiation of human dendritic cells from hematopoietic stem cells for research and immunotherapy development

Method for the in vitro differentiation of human dendritic cells from hematopoietic stem cells for research and immunotherapy development

Unmet Need Dendritic cells (DCs) play a critical role in the adaptive immune response by capturing and presenting antigens to activate cytotoxic T-cells. As such, naturally occurring DCs are thought to have crucial antitumor activity…

Read More

Intravesical UTI vaccine to induce bacteria-eradicating immune responses in the bladder

Intravesical UTI vaccine to induce bacteria-eradicating immune responses in the bladder

Unmet Need Urinary tract infections (UTI) are typically caused by uropathogenic E. coli (UPEC) that proliferate in urine and infect the urethra and bladder epithelial cells. UTIs represent the second most common bacterial infection in…

Read More

Platform for generating a seasonal vaccine for both influenza and coronaviruses

Platform for generating a seasonal vaccine for both influenza and coronaviruses

Unmet Need Similar to the flu vaccine, the need for seasonal post-immunization boosting to offer protection following COVID-19 vaccines remains possible. However, more than 8 percent of people who received a first dose of Pfizer…

Read More

Synthetic peptide adjuvants for mucosally-administered vaccines

Synthetic peptide adjuvants for mucosally-administered vaccines

Provided herein are peptides that have activity as mast cell activating proteins (MCAP), as well as compositions, adjuvant compositions, vaccines, and pharmaceutical formulations that include the peptides. Also provided are methods of using the peptides,…

Read More

Enhancing immune responses in a variety of applications with a lymph node targeting biodegradable nanoparticle

Enhancing immune responses in a variety of applications with a lymph node targeting biodegradable nanoparticle

Unmet Need While vaccines have resulted in plummeting mortality rates in the human population over the last century, significant challenges remain for which current vaccine formulations fall short. For example, current influenza vaccines are unable…

Read More

Peptide materials for immunomodulation

Peptide materials for immunomodulation

Value Proposition Glatiramoids are biomaterials synthesized for use as immunomodulators. Specifically, they are polypeptide mixtures with randomized amino acid sequences. Glatiramoids are currently FDA approved for use in multiple sclerosis. They have also been explored…

Read More

Sublingual immunization using supramolecular peptide-polymer conjugate tablets

Sublingual immunization using supramolecular peptide-polymer conjugate tablets

Value proposition Immunization with vaccines prevent illness, disability, and currently avert an estimated 2 to 3 million deaths every year. However, commonly-used vaccine technology platforms can be unpredictable, require a high manufacturing cost, and often…

Read More

A therapeutic vaccine platform for treating influenza viruses

A therapeutic vaccine platform for treating influenza viruses

Value Proposition Influenza virus infections represent a substantial global burden on human health. Each year, it is estimated that influenza viruses cause up to 5 million severe infections globally, resulting in up to 645,000 mortalities.…

Read More

Alteration of dendritic cell metabolism to augment cancer vaccine efficacy

Alteration of dendritic cell metabolism to augment cancer vaccine efficacy

Value Proposition Despite recent advances, many cancers remain refractory to available immunotherapeutic strategies. Immunotherapy is currently one of the treatment options for the 100,350 new melanomas that are estimated to be diagnosed in 2020 by…

Read More

Rapid immunoassay to detect anti-EGFRviii levels to evaluate vaccine efficacy

Rapid immunoassay to detect anti-EGFRviii levels to evaluate vaccine efficacy

Value Proposition Tumor-specific molecules offer the possibility of targeted cancer therapy using monoclonal antibodies (mAbs) specifically directed against the tumor-specific molecule. However, it has proven difficult to identify tumor-specific molecules. Overexpression of EGFR in human…

Read More

Replication competent bi- and tri-valent influenza viruses as vaccines

Replication competent bi- and tri-valent influenza viruses as vaccines

Value Proposition Influenza infection is a major public health concern, with an estimated 200,000 Americans hospitalized each year with flu or flu-related illness. The most effective method for flu prevention is vaccination, however, due to…

Read More

An adjuvant-free vaccine platform using self-assembling nanofibers

An adjuvant-free vaccine platform using self-assembling nanofibers

Value Proposition Vaccines have application for a wide range of human health conditions, including the treatment of pathogenic diseases, cancer immunotherapy, and the suppression of autoimmune disorders. In order to stimulate the immune system to…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us